HOT NEWS
Boehringer Ingelheim launches 'Lean-to-Clinic' program for fast drug product sup... » Boehringer Ingelheim has expanded its biopharmaceutical cell line development services and provides ...
43 research talents awarded scholarships to help secure Denmark's future » 43 of Denmark's most talented students in the biotechnological and pharmaceutical sciences will toda...
Novartis drug Signifor® recommended by CHMP for EU approval » The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) ado...
Genzyme Announces European Approval of Framingham Manufacturing Plant » Sanofi (EURONEXT: SAN and NYSE: SNY) and its subsidiary Genzyme announced today that the European Me...
AstraZeneca and IMS Health announce real-world evidence collaboration in Europe » AstraZeneca has entered into a three-year collaboration agreement with IMS Health, the leading provi...
MyAsthma App - a New Dimension in Asthma Control » GlaxoSmithKline (GSK) has announced the launch of MyAsthma, the UK's first, free personalised health...
Shire's Venvanse® (lisdexamfetamine dimesylate) Marketing Application accepted ... » Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced...
Bayer's Xarelto® (Rivaroxaban) Submitted for EU Marketing Authorisation for Sec... » Bayer HealthCare has submitted an application for marketing authorization to the European Medicines ...
Avastin receives EU approval for the treatment of women with newly diagnosed, ad... » Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission has approved Avastin (beva...
First-of-its-Kind Endovascular Trial of the Investigational Esprit(TM) Therapy » Abbott (NYSE: ABT) today announced the initiation of ESPRIT I, a first-of-its-kind clinical trial in...
Bristol-Myers Squibb
Bristol-Myers SquibbBristol-Myers Squibb is a global biopharmaceutical company whose mission is to extend and enhance human life. For more information, visit www.bms.com.

Bristol-Myers Squibb RSS Channel
Title Filter     Display # 
# Article Title Hits
1 Bristol-Myers Squibb Foundation Announces Six New Grants 2838
2 Bristol-Myers Squibb And Pfizer Announce Data Presentations For Apixaban 4191
3 Bristol-Myers Squibb and Roche Enter into a Clinical Collaboration Agreement 5508
4 APPRAISE-2 Study with Investigational Compound Apixaban Discontinued 8576
5 Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial Fibrillation 8350
6 Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix® 8693
7 New Online Resource Launches For Patients With Chronic Myeloid Leukemia 8208
8 Bristol-Myers Squibb Enters Global Collaboration with Nissan Chemical and Teijin Pharma 8703
9 Strong Fourth Quarter Supports Excellent 2008 for Bristol-Myers Squibb 7892
 
Bookmark and Share